A Coordinated Anti-Legalization Push Is Emerging in Early 2026

Early 2026 shows renewed pressure on cannabis reform as SAM, state AGs, and lawsuits shape a new phase of anti-legalization resistance.

In early February 2026, a surge of activity across nonprofit, state, and legal sectors signaled a sharpened front in the ongoing battle over cannabis legalization. While these actions are not formally coordinated, their timing and tone reflect a convergence of interests working to slow, stall, or outright reverse marijuana policy reform. From courtrooms to conferences, the early weeks of the year have been marked by a clear shift: opponents of cannabis normalization are no longer just pushing press releases—they’re filing lawsuits, blocking ballot measures, and pressing the federal government to retreat.

The most visible—and arguably influential—actor in this renewed posture is Smart Approaches to Marijuana (SAM), a nonprofit with a long history of opposing legalization efforts. Yet SAM is only one node in a growing network of legal, political, and advocacy pressure targeting the industry at a moment of federal uncertainty and rapid state-level change.

SAM Reemerges With Renewed Vigor

On February 6, SAM convened a high-profile conference in Washington, D.C., closed to reform advocates and independent researchers. While the event’s contents weren’t broadcast, reports indicate it served as a launchpad for the group’s 2026 agenda. Public statements following the event reaffirmed SAM’s longstanding thesis: cannabis legalization is a threat to public health, especially when wrapped in the language of normalization.

This framing is not new. What is new is the timing—and the level of investment. SAM’s push comes as federal cannabis rescheduling faces resistance, and as public attention has shifted toward practical, rather than ideological, questions about regulation, taxation, and market equity.

SAM’s renewed calls for federal intervention are also striking. The group has become more vocal in opposing the Biden administration’s December 2025 attempt to move cannabis from Schedule I to Schedule III under the Controlled Substances Act. In SAM’s view, this amounts to legitimizing a dangerous industry without meaningful public health guardrails.

Historically, SAM has had outsized influence in federal and state politics, testifying before Congress, shaping ballot initiative opposition, and generating sympathetic media coverage. Their early 2026 reemergence suggests they sense a moment of vulnerability in the legalization movement—and they’re capitalizing on it.

State Attorneys General Pick Up the Baton

The renewed energy isn’t confined to Washington. On the same day as SAM’s conference, Florida Attorney General Ashley Moody announced her office would block a 2026 referendum aimed at legalizing recreational marijuana in the state. Citing alleged flaws in ballot language and constitutional concerns, the move marks the continuation of a years-long pattern in which Florida’s executive branch has stymied cannabis reform even in the face of broad public support.

This is no isolated case. Across the country, several conservative-led states have taken steps to restrict or delay cannabis access, despite mounting evidence of popular demand. In Arizona, for example, consumer demand for infused pre-rolls and solventless concentrates has risen steadily, yet state-level rulemaking remains slow to adapt. While Arizona voters already approved adult-use cannabis in 2020, the national wave of anti-legalization energy could eventually pressure even well-established markets to harden regulations or revisit tax structures.

These state-level maneuvers, especially from attorneys general, add institutional weight to the anti-legalization camp. Even in states where legalization is on the books, elected officials with prosecutorial authority can dramatically shape how accessible, affordable, and equitable cannabis remains.

Legal Scrutiny Targets Industry Giants

Also on February 6, the Ohio Attorney General filed a sweeping antitrust lawsuit against nine multistate cannabis operators, accusing them of colluding to stifle competition and inflate prices. The move caught many by surprise, particularly as Ohio's adult-use program was still in its implementation phase following a successful 2023 ballot measure.

The implications are national. Multistate operators (MSOs) are already viewed with skepticism by many smaller brands and equity advocates, and this lawsuit amplifies concerns about monopolization in a supposedly open market. Critics argue that MSOs’ dominance threatens local operators, consumer choice, and pricing transparency.

More broadly, the lawsuit signals that cannabis companies—especially the largest ones—are vulnerable not only to regulatory risk, but to legal challenges that strike at the core of their business models. In Arizona, where market consolidation has been slower but no less steady, such litigation could embolden state regulators or prosecutors to examine competitive practices more closely. The CIGAWEEDS community, committed to Arizona-grown, independent cannabis culture, has a direct stake in whether MSOs are allowed to edge out craft and equity-led producers.

For anti-legalization groups, these lawsuits are rhetorical gold. They reinforce the narrative that the cannabis industry is chaotic, untrustworthy, and driven by profit over safety or equity. Even if the cases fail in court, the spectacle alone adds fuel to the opposition’s fire.

Federal Ambivalence Leaves Room to Maneuver

The Biden administration’s December 2025 announcement to reschedule cannabis marked a potential inflection point in federal drug policy. Yet just two months later, progress has stalled. Political infighting, bureaucratic hesitation, and opposition from influential lawmakers have all combined to delay implementation.

This vacuum creates a dangerous opportunity. With Congress gridlocked and the DEA’s next steps unclear, advocacy groups and state officials are stepping into the breach. They’re filling the policy gap not with reform, but with retrenchment.

Federal courts are also increasingly active in cannabis-related cases, from taxation disputes under Section 280E of the IRS code to challenges against interstate commerce bans. These cases, often overlooked by the general public, are critical arenas in shaping the future of legalization. Legal precedent now moves faster than legislation—and anti-cannabis forces appear eager to use it.

Arizona is not immune. As legal uncertainties ripple outward, local businesses face growing compliance costs and legal ambiguity. For CIGAWEEDS and similar players, the path forward demands both legal vigilance and grassroots advocacy, lest national backsliding undercut hard-won state-level gains.

Not a Conspiracy, but a Convergence

It would be easy to frame this moment as a secret, coordinated campaign to roll back cannabis rights. The truth is more nuanced. What we are witnessing is a convergence: of nonprofit opposition, state-level resistance, and legal action, all happening against a backdrop of federal inaction.

These actors are not all reading from the same playbook. Still, their actions echo one another and feed a shared narrative—that legalization is unraveling, or at least not as inevitable as once assumed. Each lawsuit, blocked ballot, or alarmist press release reinforces the others.

For Arizona’s cannabis market, this convergence matters. Public opinion remains broadly supportive of legalization, but political and legal momentum often runs ahead of—or against—popular will. Maintaining the progress made since Prop 207 will require vigilance, not complacency.

What Comes Next

The year ahead will test the cannabis movement’s resilience. Gone are the days when cultural normalization alone could drive reform. In its place is a harder, more procedural battle, waged in courtrooms, policy memos, and administrative rulebooks.

Legalization advocates and industry players must prepare for sustained legal and regulatory pushback. The tempo of reform will slow. Political polarization will deepen. Lawsuits will multiply. None of this is surprising—but it demands a recalibrated response.

In Arizona, that means doubling down on transparency, fairness, and community engagement. It also means strengthening connections between patient advocacy, industry innovation, and regulatory compliance.

For CIGAWEEDS, whose roots run deep in local cannabis culture, this moment is not just a call to clarify purpose and defend the gains we’ve made, it’s an inflection point whose consequences will reverberate throughout the cannabis community and the industry nationwide.

February 2026 may be remembered as the moment the anti-legalization movement found its footing again. Whether it represents a short-term reaction or a long-term shift remains uncertain. What is clear is that cannabis reform is entering a new phase—one where opposition moves quietly through the courts and agencies rather than shouting from the pulpit.

Those committed to fair, accessible cannabis must meet that shift head-on.

***

Cigaweeds is the ultimate choice for discreet and convenient cannabis prerolls. Made with premium flower and natural hemp tips, our prerolls deliver a smooth and satisfying smoke every time. Whether you prefer indica, sativa, or hybrid strains, we have something for you. Our products are lab-tested and compliant with state regulations, ensuring quality and safety. You can find our prerolls at select retailers across Arizona, or order online and get them delivered to your door. Cigaweeds also collaborates with High Grade, a leading cultivator of exotic and rare cannabis strains, to bring you exclusive and limited-edition prerolls that will blow your mind.

Visit our website to learn more about our strains, our blog, and our store. 

Follow us on Instagram to stay updated on the latest news and promotions.